Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Respiratory and Critical Care Medicine
|
April 28, 2017
Triplicate Sputum Cultures for Efficacy Evaluation of Novel Antituberculosis Regimens
Andreas H Diacon, Elana van Brakel, Nacer Lounis, et al.
Plos One
|
July 20, 2018
Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial
Paul Meyvisch, Chrispin Kambili, Koen Andries, et al.
Antiviral Therapy
|
October 26, 2011
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial
Michael Manns, Henk Reesink, Thomas Berg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 15, 2013
Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients
Hans-Jürgen Stellbrink, Keikawus Arastéh, Dirk Schürmann, et al.
Advances in Therapy
|
October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
Eva Santermans, Paul Ford, Michael Kreuter, et al.
Annals of the Rheumatic Diseases
|
April 17, 2026
Efgartigimod in Sjögren's disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO)
Isabelle Peene, Gwenny M Verstappen, Suzanne Arends, et al.
Gastroenterology
|
October 27, 2009
Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients
Henk W Reesink, Gregory C Fanning, Khalid Abou Farha, et al.
The European Respiratory Journal
|
December 10, 2015
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Alexander S Pym, Andreas H Diacon, Shen-Jie Tang, et al.
The New England Journal of Medicine
|
August 21, 2014
Multidrug-resistant tuberculosis and culture conversion with bedaquiline
Andreas H Diacon, Alexander Pym, Martin P Grobusch, et al.
The New England Journal of Medicine
|
June 5, 2009
The diarylquinoline TMC207 for multidrug-resistant tuberculosis
Andreas H Diacon, Alexander Pym, Martin Grobusch, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Respiratory and Critical Care Medicine
|
April 28, 2017
Triplicate Sputum Cultures for Efficacy Evaluation of Novel Antituberculosis Regimens
Andreas H Diacon, Elana van Brakel, Nacer Lounis, et al.
Plos One
|
July 20, 2018
Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial
Paul Meyvisch, Chrispin Kambili, Koen Andries, et al.
Antiviral Therapy
|
October 26, 2011
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial
Michael Manns, Henk Reesink, Thomas Berg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 15, 2013
Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients
Hans-Jürgen Stellbrink, Keikawus Arastéh, Dirk Schürmann, et al.
Advances in Therapy
|
October 1, 2019
Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
Eva Santermans, Paul Ford, Michael Kreuter, et al.
Annals of the Rheumatic Diseases
|
April 17, 2026
Efgartigimod in Sjögren's disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO)
Isabelle Peene, Gwenny M Verstappen, Suzanne Arends, et al.
Gastroenterology
|
October 27, 2009
Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients
Henk W Reesink, Gregory C Fanning, Khalid Abou Farha, et al.
The European Respiratory Journal
|
December 10, 2015
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Alexander S Pym, Andreas H Diacon, Shen-Jie Tang, et al.
The New England Journal of Medicine
|
August 21, 2014
Multidrug-resistant tuberculosis and culture conversion with bedaquiline
Andreas H Diacon, Alexander Pym, Martin P Grobusch, et al.
The New England Journal of Medicine
|
June 5, 2009
The diarylquinoline TMC207 for multidrug-resistant tuberculosis
Andreas H Diacon, Alexander Pym, Martin Grobusch, et al.
Page
of 2